Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy. 2005

Oliver Zimmermann, and Matthias Kochs, and Thomas Paul Zwaka, and Ziya Kaya, and Philipp Moritz Lepper, and Magdalena Bienek-Ziolkowski, and Martin Hoher, and Vinzenz Hombach, and Jan Torzewski
Department of Internal Medicine II-Cardiology, University of Ulm, Robert-Koch-Str. 8, 89081 Ulm, Germany. oliver.zimmermann@medizin.uni-ulm.de

BACKGROUND We investigated whether myocardial biopsy analysis for inflammation and viruses correlates with outcome in dilated cardiomyopathy. METHODS Myocardial biopsies of 82 patients were analyzed for HLAI, HLAII, CD54, CD2, CD68 and entero-/adenovirus. Ejection fraction was determined by left ventriculography. NYHA classification, electrocardiogram (ECG) and echocardiography were analyzed at first admission and for follow up. Patients were attributed to three groups: (A) no inflammation/no virus (B) inflammation/no virus (C) virus with/without inflammation. Patients not responding to conventional treatment of heart failure received interferon beta1b (group C) or prednisolone (group B). Median follow up was 7 months (group A), 11 months (group B) and 14.5 months (group C). RESULTS Thirty nine patients (48%) belonged to group A, 33 patients (40%) to group B, 10 patients (12%) to group C. Only enterovirus was detected. Ejection fraction at admission was worse for group B compared to group A (p=0.003). Groups A and B improved for echocardiography and NYHA (p< or =0.001). Group C improved for echocardiography only (p=0.031). Group B showed a better outcome for echocardiography (p=0.014) and NYHA (p=0.023) than group A. CONCLUSIONS Inflammatory cardiomyopathy shows the best outcome. Antiinflammatory or antiviral treatment may be an option in patients not responding to conventional therapy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009205 Myocarditis Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies. Carditis,Myocarditides
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D002311 Cardiomyopathy, Dilated A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein. Cardiomyopathy, Congestive,Congestive Cardiomyopathy,Dilated Cardiomyopathy,Cardiomyopathy, Dilated, 1a,Cardiomyopathy, Dilated, Autosomal Recessive,Cardiomyopathy, Dilated, CMD1A,Cardiomyopathy, Dilated, LMNA,Cardiomyopathy, Dilated, With Conduction Defect 1,Cardiomyopathy, Dilated, with Conduction Deffect1,Cardiomyopathy, Familial Idiopathic,Cardiomyopathy, Idiopathic Dilated,Cardiomyopathies, Congestive,Cardiomyopathies, Dilated,Cardiomyopathies, Familial Idiopathic,Cardiomyopathies, Idiopathic Dilated,Congestive Cardiomyopathies,Dilated Cardiomyopathies,Dilated Cardiomyopathies, Idiopathic,Dilated Cardiomyopathy, Idiopathic,Familial Idiopathic Cardiomyopathies,Familial Idiopathic Cardiomyopathy,Idiopathic Cardiomyopathies, Familial,Idiopathic Cardiomyopathy, Familial,Idiopathic Dilated Cardiomyopathies,Idiopathic Dilated Cardiomyopathy
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

Oliver Zimmermann, and Matthias Kochs, and Thomas Paul Zwaka, and Ziya Kaya, and Philipp Moritz Lepper, and Magdalena Bienek-Ziolkowski, and Martin Hoher, and Vinzenz Hombach, and Jan Torzewski
November 1988, Kokyu to junkan. Respiration & circulation,
Oliver Zimmermann, and Matthias Kochs, and Thomas Paul Zwaka, and Ziya Kaya, and Philipp Moritz Lepper, and Magdalena Bienek-Ziolkowski, and Martin Hoher, and Vinzenz Hombach, and Jan Torzewski
September 2005, Medizinische Klinik (Munich, Germany : 1983),
Oliver Zimmermann, and Matthias Kochs, and Thomas Paul Zwaka, and Ziya Kaya, and Philipp Moritz Lepper, and Magdalena Bienek-Ziolkowski, and Martin Hoher, and Vinzenz Hombach, and Jan Torzewski
November 2010, Nuclear medicine communications,
Oliver Zimmermann, and Matthias Kochs, and Thomas Paul Zwaka, and Ziya Kaya, and Philipp Moritz Lepper, and Magdalena Bienek-Ziolkowski, and Martin Hoher, and Vinzenz Hombach, and Jan Torzewski
July 2022, Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference,
Oliver Zimmermann, and Matthias Kochs, and Thomas Paul Zwaka, and Ziya Kaya, and Philipp Moritz Lepper, and Magdalena Bienek-Ziolkowski, and Martin Hoher, and Vinzenz Hombach, and Jan Torzewski
July 2019, Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference,
Oliver Zimmermann, and Matthias Kochs, and Thomas Paul Zwaka, and Ziya Kaya, and Philipp Moritz Lepper, and Magdalena Bienek-Ziolkowski, and Martin Hoher, and Vinzenz Hombach, and Jan Torzewski
August 1998, Clinical cardiology,
Oliver Zimmermann, and Matthias Kochs, and Thomas Paul Zwaka, and Ziya Kaya, and Philipp Moritz Lepper, and Magdalena Bienek-Ziolkowski, and Martin Hoher, and Vinzenz Hombach, and Jan Torzewski
November 1983, Journal of the American College of Cardiology,
Oliver Zimmermann, and Matthias Kochs, and Thomas Paul Zwaka, and Ziya Kaya, and Philipp Moritz Lepper, and Magdalena Bienek-Ziolkowski, and Martin Hoher, and Vinzenz Hombach, and Jan Torzewski
January 1994, Journal of computer assisted tomography,
Oliver Zimmermann, and Matthias Kochs, and Thomas Paul Zwaka, and Ziya Kaya, and Philipp Moritz Lepper, and Magdalena Bienek-Ziolkowski, and Martin Hoher, and Vinzenz Hombach, and Jan Torzewski
July 1993, The Journal of clinical investigation,
Oliver Zimmermann, and Matthias Kochs, and Thomas Paul Zwaka, and Ziya Kaya, and Philipp Moritz Lepper, and Magdalena Bienek-Ziolkowski, and Martin Hoher, and Vinzenz Hombach, and Jan Torzewski
October 1985, Cardiologia (Rome, Italy),
Copied contents to your clipboard!